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OVERVIEW — Oversight of private insurance, including health

insurance, is primarily a state responsibility. Each state establishes
its own laws and regulations regarding insurer activities, including
premium increases for the insurance products within its purview.
The authority that state regulators have to review and deny requests
for premium changes varies from state to state, as do the amount
of resources available to state insurance departments for reviewing
premium changes. In some markets where insurers have proposed or
implemented steep increases, such changes have received considerable attention from the press, state regulators, and policymakers.
The Patient Protection and Affordable Care Act (PPACA) requires
annual review of premium increases and disclosure of those
increases determined unreasonable beginning in September 2011.
Under PPACA, each state will conduct these reviews for individual
and small-group health insurance unless the federal government
concludes they do not have an effective review program and
assumes review responsibility. As they did prior to PPACA, state
laws govern whether rates go into effect and establish the parameters
of regulators’ authority. This issue brief outlines specific state and
federal roles in the rate review process and changes to rate review
processes since PPACA was enacted.
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ndividual and small-group coverage is typically purchased
from insurers, which are regulated by the states, while most
(though not all) large-group coverage is purchased from selffunded employers, which are not subject to state regulation.1
Nationally, about 14 million2 people were covered by individual (also called non-group) insurance and about 22 million3
workers and dependents were covered by a small-group employer policy in 2010. Enrollees or employers on behalf of their
employees pay a premium in exchange for a pre-determined
set of health benefits under their health insurance. Insurers
calculate premiums (or rates) using “actuarial estimates of the
cost of providing coverage over a period of time to policyholders and enrollees in a health plan.”4 Policyholders may face
premium changes each year that reflect actuarial analysis of
the changes in the underlying costs of insurance—price and
utilization of services, administrative costs, profit, and other
factors.5 According to the Kaiser/HRET survey of employersponsored health benefits, premiums for family coverage have
increased between 2001 and 2011 at an average annual rate of
7.3 percent for firms with 3 to 199 workers and 8.1 percent for
firms with 200 or more workers.6 Data on premiums and premium trends for people with individual health insurance are
scant, but one nationally representative survey of people with
individual health insurance in 2010 found that 77 percent faced
a premium increase at their last renewal, with annual increases averaging 20 percent among those experiencing increases.7
A number of steep premium increases for individual and smallgroup policies, as well as instances of insurer miscalculations, have
called attention to the increasing cost of coverage, the lack of information about what drives premium increases, and states’ authority and
resources to oversee insurer conduct. Anthem Blue Cross of California’s request in February 2010 for a 39 percent increase in health insurance premiums in the individual market received national attention. After delaying implementation of the new rates, an independent
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actuary hired by the state to review Anthem’s filings discovered errors in its calculations, resulting in Anthem withdrawing its request
and seeking a lower average increase of 14 percent and a maximum
of 20 percent.8 Certainly, rate increases are not always the result of
errors, but this case highlights the potential benefit to enrollees when
insurers’ calculations are reviewed independently.

STATE AUTHORIT Y TO RE VIE W AND A PPROVE R ATES
Regulation and licensure of health insurance is primarily a state responsibility.9 Requirements for insurance carriers are generally enforced by
a state department of insurance and the state insurance commissioner.
Each state establishes its own laws and regulations for aspects of insurers’ activities, such as financial standards, market conduct, contracts,
consumer complaints, and premium rates for the health insurance
products it regulates. States may have different requirements for different market segments—individual, small-, or large-group policies—or
for different product types such as HMOs, PPOs, or indemnity plans.
States may define market segments differently, but most define a small
employer as having 2 or more but not more than 50 employees and a
large employer as having at least 51 employees.10
One way that states exercise their regulatory authority is by requiring
insurers to file information about rates and, in some cases, requests to
increase rates, prior to implementing them.11 Rates are typically “filed
as a formula that describes how to calculate a premium for each person or family covered, based on information such as geographic location, underwriting class, coverage and co-payments, age, gender, and
number of dependents.”12 Oversight requirements for insurers’ rates
“are used to help ensure that premium rates are adequate, not excessive, reasonable in relation to the benefits provided, and not unfairly
discriminatory.”13 As with other regulated aspects of insurer conduct,
states vary in their requirements for notifying state regulators of rate
changes and providing information to justify those changes. State
regulators’ authority to review and deny requests for rate changes also
varies, as does the amount of resources available to state insurance
departments for reviewing rates and the information required. Most
states require rates and supporting information to be filed with the
state, though some require it only for HMOs or BlueCross BlueShield
plans, or if there is a rate increase proposed. As of December 2010, ten
states did not require such rate filings and instead require actuarial
certification that the rates comply with state laws.14
3
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States’ rate review authority falls largely into two categories: “file and
use” and “prior approval.” In states with file and use authority, rates
once filed with the state can go into effect on a specified date without
state approval. In states with prior approval authority, state regulators may review rate filings and approve or disapprove rates based on
their analysis of insurers’ assumptions and calculations before they go
into effect. In some states with prior approval authority, the rates are
deemed approved if the state does not take action within a specified
period, typically 30 or 60 days. Thirty-four states and the District of
Columbia have prior approval authority over the individual or smallgroup markets.15 In 13 of those states, that authority is limited to the
individual market, the small-group market, or certain product types.
As noted in a December 2010 report that looked in-depth at the review
authority and practices in 10 states, a state’s statutory authority to review rate increases does not provide detail about the rigor of the rate
review process, nor does a state insurance department’s prior approval
authority over rates necessarily preclude large rate increases from taking effect. How reviews are conducted and what actions are taken “can
vary widely from state to state, depending on motivation, resources,
and staff capacity.”16 A July 2011 U.S. Government Accountability Office (GAO) report observed such variation in states’ authorities, but
also found that “not all variation in states’ practices was consistent
with differences in state insurance departments’ authorities to review
and approve or disapprove rate filings.”17 The report examined states’
oversight of private health insurance premium rates and reported the
results of a state survey of insurance commissioners. It found variation in state authority to review rate filings and variation in practices
such as the timing of reviews, the type of information considered, and
opportunities for consumer input. The survey also found variation in
the comprehensiveness of states’ reviews, for example:
Survey respondents from Texas reported that for all filings reviewed,
all assumptions, including the experience underlying the assumptions,
were reviewed by department actuaries for reasonableness, while respondents from Pennsylvania and Missouri reported that they did not
always perform a detailed review of information provided in rate filings.
Respondents from Pennsylvania reported that while they compared data
submitted by carriers in rate filings to the carriers’ previous rate filings,
the state’s department of insurance did not have adequate capacity to
perform a detailed review of all rate filings received from carriers. Respondents from Missouri reported that they looked through the information provided by carriers in rate filings in 2010, but that they did not have
the authority to do a more comprehensive review.18
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RE V IE W A N D DI SC LOSU RE O F
U N RE A S O N A BLE P REM I U M I N C RE A SES
The Patient Protection and Affordable Care Act (PPACA, P.L. 111148), passed on March 23, 2010, and amended by the Health Care
Education Reconciliation Act (P.L. 111-152), requires the Secretary of
the Department of Health and Human Services (HHS), in conjunction with the states, to establish and carry out a process for the annual review and disclosure of unreasonable health insurance premium increases.19 The final rule implementing the annual review
and disclosure provision establishes standards and processes for

Characteristics of an Effective State Rate Review System
The Center for Consumer Information and Insurance Oversight (CCIIO), a division of the Centers for Medicare &
Medicaid Services (CMS), determines a state’s rate review system to be effective if it :

• Receives sufficient data and documentation concerning rate increases to conduct an examination of the reasonableness of the proposed increases.

• Considers several factors as they apply to the review:
{{

Medical cost trend changes by major service categories

{{

Changes in utilization of services (i.e., hospital care, pharmaceuticals, office visits) by major service categories

{{

Cost-sharing changes by major service categories

{{

Changes in benefits

{{

Changes in enrollee risk profile

{{

Impact of over- or underestimate of medical trend in previous years on the current rate

{{

Reserve needs

{{

Administrative costs related to programs that improve health care quality

{{

Other administrative costs

{{

Applicable taxes and licensing or regulatory fees

{{

Medical loss ratio

{{

The issuer’s capital and surplus.

• Makes a determination of the reasonableness of the rate increase under a standard set forth in state statute or
regulation.

• Posts either rate filings under review or preliminary justifications on their websites, or posts a link to the preliminary justifications that appear on the CMS website.

• Provides a mechanism for receiving public comments on proposed rate increases.
• Reports results of rate reviews to CMS for rate increases subject to review.
Source: “Health Insurance Rate Review: Lowering Costs for American Consumers and Businesses,” Center for Consumer Information & Insurance
Oversight, Centers for Medicare & Medicaid Services, fact sheet, available at http://cciio.cms.gov/resources/factsheets/rate_review_fact_sheet.html.
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determining whether a premium increase is unreasonable and requirements for public notification of unreasonableness; it is effective
for rate changes scheduled on or after September 1, 2011.20 Insurers
are required to submit justification for rates that meet or exceed the
minimum threshold for review—10 percent in 2011—and either the
state or CMS will determine whether the increase is unreasonable.
In states deemed to have effective rate review programs, CMS will
adopt the states’ assessments of the reasonableness of a submitted
rate; in states without effective programs, the federal government
will assess reasonableness. State laws and regulations regarding rate
review and approval authority still apply to insurers in the state, and
rates deemed unreasonable under the federal process may still go
into effect depending on state law. Requirements for disclosure and
review of unreasonable premium increases apply to individual and
small-group health insurance plans, but do not apply to large-group
plans, grandfathered21 plans, or insurance coverage that meets the
definition of “excepted benefits” (for example, limited scope dental
and vision).
C M S : M o s t St a te ’s Ra te Rev iew P ro g ra m s Ef f e c ti ve

To determine readiness to assist with the PPACA-mandated rate
review and disclosure provisions, CMS evaluated each state’s current review process and determined whether it has an effective rate
review program for individual and small-group market products.
(See text box for characteristics of an effective rate review system.)
Based on its review and evaluation, CMS announced that, as of August 22, 2011:
• 42 states, the District of Columbia, and the U.S. Virgin Islands
have effective review for all insurance markets and issuers;
• 2 states (Pennsylvania and Virginia) have effective rate review for
the individual market and the federal government will review
small-group rates;
• 6 states (Alabama, Arizona, Louisiana, Missouri, Montana, and
Wyoming) and four U.S. territories (American Samoa, Guam,
Northern Mariana Islands, and Puerto Rico) were found not to
have effective rate review programs, and the federal government
will review rates to determine reasonableness.
PPACA required the Secretary to award grants to states during the
five-year period beginning with fiscal year 2010 to help states carry
6
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out premium reviews and provide information to the Secretary.22 The
law appropriated $250 million to be available for spending under the
grants program. On August 16, 2010, HHS announced the first round
of grants to states who applied for awards; each of the 45 states that
applied plus the District of Columbia were awarded $1 million to
enhance their current processes for reviewing health insurance premium increases. Five states—Alaska, Georgia, Iowa, Minnesota, and
Wyoming—did not apply for the first round of grant funding. In
their applications, states outlined their intended use of grant funds
for pursuing additional legislative authority (18 states and DC), expanding the scope of their current health insurance review process
(21 states and DC), implementing a more extensive and detailed review process (46 states), making more information available to the
public (42 states and DC), and upgrading necessary technology (all
grant recipients).23 Twenty-one states addressed changes to premium
rate review in their 2011 legislative session and, as of July 21, 2011,
nine states—Hawaii, Maine, New Mexico, New York, North Dakota,
Tennessee, Utah, Vermont, and Washington—passed laws to change
their rate review processes.24 A second round of grants to states was
announced in February 2011.25 Those grants, totaling $109 million,
were awarded to 28 states and the District of Columbia on September 20, 2011. States receiving the second-round grants have proposed
to use the funding to introduce legislation to strengthen authority to
review or publish rate increases, expand the scope of their review,
bolster the information required from insurers, enhance consumer
access to information about rate review, hire new staff, and improve
information technology.26
D e f inin g a n d D e te r minin g
“U n rea s o na b l e” Ra te I n crea s e s

According to the regulation, the first step to determining whether rate
increases are unreasonable is for CMS or the state to review rate increases that meet or exceed specified thresholds. In the first year of
the review process, an increase in the rate27 in the individual or smallgroup market is subject to review if it is at least 10 percent more than
the previous year’s rate. After the first year, state-specific thresholds
will apply.28 State-specific thresholds will be published no later than
June 1 of each year and will be effective September 1 of that year.
For states determined to have effective rate review programs, CMS
will adopt the states’ assessments of unreasonableness of a submitted
7
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rate. A state’s final determination must include an explanation of its
analysis and be provided to CMS within ten business days following
its determination. For states lacking effective rate review programs,
CMS will review submitted rate increases. It will use three tests to
determine whether a rate increase is excessive, unjustified, or unfairly discriminatory and therefore unreasonable. An increase will
be determined29:
• excessive if it causes the premium to be unreasonably high relative to the benefits of the policy. CMS will consider “whether (1)
the rate increase would result in a projected medical loss ratio
below the applicable federal standard; (2) one or more of the assumptions is not supported by substantial evidence; and (3) the
choice of assumptions is unreasonable.”
• unjustified “if the issuer provides data or documentation that is
incomplete, inadequate, or otherwise does not provide a basis to
determine whether the increase is unreasonable.”
• unfairly discriminatory “if it results in premium differences between insured people with similar risks that are not permitted
under State law or, if there is no applicable State law, does not
reasonably correspond to expected differences in costs.”
J u s tif i c a tio n fo r Ra te I n crea s e s S u b je c t to Rev iew

The PPACA rule establishes requirements for health insurers to submit a preliminary justification to CMS and applicable states for all
rate increases subject to review. The health insurance issuer must
send CMS and the state the preliminary justification (i) prior to the
implementation of the rate increase, in states that do not require a
proposed rate increase to be filed prior to implementation of the increase, or (ii) on the date the issuer submits the proposed increase
to the state, in states that require a proposed rate increase to be filed
with the state prior to implementation.
The preliminary justification has three parts. Part I, the “rate increase summary,” must include:
• historical and projected claims experience,
• trend projections related to utilization and service or unit cost,
• claims assumptions related to benefit changes,

8
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• allocation of the overall rate increase to claims and non-claims
costs,
• per-enrollee per-month allocation of current and projected premium, and
• three year history of rate increases for the product associated with
the rate increase.
Part II, the “written description justifying the rate,” is a “simple and
brief narrative describing the data and assumptions used to develop
the rate increase, the most significant factors causing the increase,
and a brief description of the policies’ overall experience.” Part III
is the “rate filing documentation,” which must be provided to CMS
when it is reviewing the rate increase; for states with effective review
processes CMS will accept a copy of a rate filing submitted to a state
that included each of these elements. Part III must include:
• a description of the type of policy, benefits, renewability, general
marketing method, and issue age limits;
• scope and reason for the rate increase;
• average annual premium per policy, before and after the rate
increase;
• past experience and any other alternative or additional data used;
• a description of how the rate increase was determined, including
the general description and source of each assumption used;
• the cumulative loss ratio and a description of how it was calculated;
• the projected future loss ratio and a description of how it was
calculated;
• the projected lifetime loss ratio that combines cumulative and future experience and a description of how it was calculated;
• the federal medical loss ratio standard in the applicable market to
which the rate increase applies, accounting for any adjustments
allowable under federal law; and
• if the projected future loss ratio is less than the applicable federal
medical loss ratio, a justification for this outcome.
The information on Parts I and II will be available for review through
the HealthCare.gov website. Information not deemed confidential in
Part III will be on CCIIO’s website.

9
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P u b li c Re l ea s e of Rev iew O u tco m e s a n d
U n rea s o na b l e Ra te I n crea s e Fin din g s

The final determination of whether a rate increase is unreasonable
will be posted on the CMS website and the insurer’s website. If CMS
has reviewed the increase, its determination and a brief explanation of its analysis will be posted within five business days. CMS
will also provide this information to the health insurance issuer in
cases when the increase is determined to be unreasonable. As mentioned above, CMS will adopt the state’s final determination in states
deemed to have an effective review process. In states where the state
determines that the rate increase is unreasonable, but the insurer is
permitted to implement the increase under state law, CMS will provide the state’s final determination and explanation to the insurance
issuer within five business days of CMS receiving the information
from the state.
Health insurers that implement unreasonable rate increases must
provide CMS with a “final justification” responding to CMS’s or the
state’s determination within ten days of implementing the increase or
receiving the final determination. Health insurers must also prominently post on their website: (i) the portions of the preliminary justification posted on the CMS website; (ii) CMS’s or the state’s final determination; and (iii) the issuer’s final justification. This information
must be made available on the issuer’s website for at least three years.
In addition, CMS will make an issuer’s final justification available on
HealthCare.gov for three years. HHS released a preview of the publicly available rate review tool for consumers on September 1, 2011.30

CO N C LU S I O N
The PPACA provisions requiring rate review and disclosure maintain state responsibility for regulation of insurance and do not prohibit insurers from implementing rate increases deemed excessive
under the federal definition for non-grandfathered individual and
small-group health insurance plans where states do not have authority to disapprove rates. Rather, the law requires disclosure of
information about premium increases and their basis to regulators.
Regulators expect that this scrutiny, in combination with the subsequent public disclosure about rates deemed excessive and other
policy changes such as minimum medical loss ratio requirements
for health insurers, will help to moderate premiums for consumers
10
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purchasing individual or small-group insurance policies. The effectiveness of the rate review and disclosure process to moderate unreasonable premium increases depends on adequate capacity in the
states and in the federal government to manage the review process
and consumer access to information, which will likely be enhanced
by grant funding. The authority that states have to disapprove unreasonable rates, which is not directly affected by the PPACA requirements, will also still play an important role in the moderation
of premium increases. Although the process will not prohibit a justifiably steep rate increase from going into effect, the information
required on the justification forms will provide valuable insight into
the extent to which different drivers of premiums, such as price and
use of medical services, the risk profile of covered populations, and
administrative costs, change from year to year and contribute to premium increases.
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